Model-based exposure-response analysis to quantify age related differences in the response to scopolamine in healthy subjects-Reference-Cited by-同舟云学术

Model-based exposure-response analysis to quantify age related differences in the response to scopolamine in healthy subjects

Published:2016-07-14 Issue:4 Volume:82 Page:1011-1021
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Alvarez-Jimenez Ricardo¹^ORCID,Groeneveld Geert Jan¹²,van Gerven Joop M. A.¹³,Goulooze Sebastiaan C.¹⁴^ORCID,Baakman Anne Catrien¹,Hay Justin L.¹,Stevens Jasper¹

Affiliation:

1. Centre for Human Drug Research; 2333 CL Leiden the Netherlands

2. Neurology Department; VU University Medical Center; 1081 HV Amsterdam the Netherlands

3. Neurology Department; Leiden University Medical Center; 2333 ZA Leiden the Netherlands

4. Leiden Academic Center for Drug Research, Division of Pharmacology, Faculty of Mathematics and Natural Sciences; Leiden University; 2333 CC Leiden the Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13031/fullpdf

Reference39 articles.

1. The cholinergic hypothesis of geriatric memory dysfunction;Bartus;Science,1982

2. Alzheimer's disease: a disorder of cortical cholinergic innervation;Coyle;Science,1983

3. Insights into the ageing mind: a view from cognitive neuroscience;Hedden;Nat Rev Neurosci,2004

4. Regional brain changes in aging healthy adults: General trends, individual differences and modifiers;Raz;Cereb Cortex,2005

5. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease;Mufson;J Comp Neurol,2000

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EEG changes as an indication of central nervous system involvement following cyclopentolate 1% eye drops; a randomized placebo-controlled pilot study in a pediatric population;Strabismus;2023-04-03

2. Acute response to cholinergic challenge predicts long‐term response to galantamine treatment in patients with Alzheimer's disease;British Journal of Clinical Pharmacology;2022-01-26

3. Effects of New Galantamine Derivatives in a Scopolamine Model of Dementia in Mice;Journal of Alzheimer's Disease;2021-11-09

4. Biperiden Challenge Model in Healthy Elderly as Proof‐of‐Pharmacology Tool: A Randomized, Placebo‐Controlled Trial;The Journal of Clinical Pharmacology;2021-07-29

5. The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs;Pharmacology Research & Perspectives;2021-05